Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $89,279 | 48 | 42.7% |
| Food and Beverage | $59,766 | 1,616 | 28.6% |
| Education | $26,907 | 22 | 12.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $11,375 | 7 | 5.4% |
| Travel and Lodging | $10,608 | 48 | 5.1% |
| Unspecified | $9,890 | 18 | 4.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 2 | 0.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PAINTEQ LLC | $85,538 | 177 | $0 (2024) |
| Saluda Medical Americas, Inc. | $53,480 | 136 | $0 (2024) |
| Abbott Laboratories | $37,910 | 360 | $0 (2024) |
| Nevro Corp. | $5,642 | 94 | $0 (2024) |
| Boston Scientific Corporation | $3,440 | 51 | $0 (2024) |
| Medtronic, Inc. | $3,314 | 48 | $0 (2024) |
| BIOTRONIK NRO, Inc. | $1,978 | 56 | $0 (2024) |
| Medtronic USA, Inc. | $1,700 | 22 | $0 (2020) |
| ABBVIE INC. | $1,609 | 78 | $0 (2024) |
| SPR Therapeutics, Inc | $1,349 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,651 | 254 | Saluda Medical Americas, Inc. ($33,696) |
| 2023 | $46,441 | 253 | Saluda Medical Americas, Inc. ($19,515) |
| 2022 | $59,786 | 290 | PAINTEQ LLC ($39,936) |
| 2021 | $34,176 | 207 | PAINTEQ LLC ($22,564) |
| 2020 | $3,691 | 130 | Abbott Laboratories ($2,188) |
| 2019 | $8,968 | 190 | Abbott Laboratories ($3,205) |
| 2018 | $4,472 | 199 | Abbott Laboratories ($2,510) |
| 2017 | $4,141 | 238 | Abbott Laboratories ($1,413) |
All Payment Transactions
1,761 individual payment records from CMS Open Payments — Page 1 of 71
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $22.88 | General |
| 12/20/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/18/2024 | Medtronic, Inc. | ACCURIAN (Device) | Food and Beverage | In-kind items and services | $57.29 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 12/18/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $38.83 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/12/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $68.99 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.98 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Not Applicable | ||||||
| 12/11/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Not Applicable | ||||||
| 12/09/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $63.03 | General |
| Category: Neuromodulation | ||||||
| 12/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $5.72 | General |
| 12/05/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Opioid Analgesic | ||||||
| 12/04/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Not Applicable | ||||||
| 12/03/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: Not Applicable | ||||||
| 12/02/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/26/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Neuromodulation | ||||||
| 11/25/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $87.41 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/25/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $37.46 | General |
| Category: Pain management | ||||||
| 11/25/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $83.75 | General |
| Category: Neuromodulation | ||||||
| 11/19/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.24 | General |
| Category: Opioid Analgesic | ||||||
| 11/13/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $113.89 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/13/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $37.72 | General |
| Category: WaveWriter Alpha_NMD | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| SECURE Study | PAINTEQ LLC | $5,420 | 10 |
| Secure Study | PAINTEQ LLC | $4,470 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 579 | 1,453 | $738,125 | $128,554 |
| 2022 | 20 | 612 | 1,546 | $754,714 | $138,701 |
| 2021 | 19 | 729 | 1,835 | $689,530 | $161,925 |
| 2020 | 21 | 679 | 1,598 | $618,607 | $129,350 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 205 | 836 | $188,100 | $84,226 | 44.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $30,600 | $9,188 | 30.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 37 | 40 | $51,200 | $7,916 | 15.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 61 | 94 | $141,000 | $7,332 | 5.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 31 | 56 | $70,400 | $5,281 | 7.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 39 | 52 | $130,500 | $4,729 | 3.6% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 23 | 29 | $23,200 | $2,252 | 9.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 11 | 13 | $10,400 | $2,077 | 20.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 15 | 16 | $30,000 | $1,572 | 5.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 20 | $22,400 | $1,236 | 5.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 19 | 20 | $10,800 | $1,121 | 10.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 13 | 23 | $22,400 | $1,029 | 4.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 11 | 11 | $2,750 | $458.20 | 16.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 32 | 175 | $4,375 | $138.44 | 3.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 197 | 822 | $184,950 | $86,440 | 46.7% |
| 27279 | Fusion of pelvic joint using imaging guidance | Facility | 2022 | 11 | 11 | $38,500 | $7,855 | 20.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $23,400 | $6,770 | 28.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 30 | 32 | $39,200 | $6,563 | 16.7% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2022 | 48 | 62 | $93,000 | $5,096 | 5.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2022 | 40 | 53 | $117,000 | $4,532 | 3.9% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 21 | 42 | $53,600 | $4,137 | 7.7% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 15 | 17 | $14,400 | $2,807 | 19.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2022 | 15 | 23 | $18,400 | $2,012 | 10.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 19 | 33 | $31,200 | $1,988 | 6.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 12 | 18 | $36,000 | $1,888 | 5.2% |
About Dr. Patrick Buchanan, M.D
Dr. Patrick Buchanan, M.D is a Interventional Pain Medicine healthcare provider based in Camarillo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2011. The National Provider Identifier (NPI) number assigned to this provider is 1275828568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Buchanan, M.D has received a total of $209,325 in payments from pharmaceutical and medical device companies, with $47,651 received in 2024. These payments were reported across 1,761 transactions from 75 companies. The most common payment nature is "Consulting Fee" ($89,279).
As a Medicare-enrolled provider, Buchanan has provided services to 2,599 Medicare beneficiaries, totaling 6,432 services with total Medicare billing of $558,531. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Interventional Pain Medicine
- Location Camarillo, CA
- Active Since 06/14/2011
- Last Updated 08/30/2016
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1275828568
Products in Payments
- PAINTEQ (Device) $85,538
- Evoke (Device) $33,696
- Evoke SCS (Device) $19,784
- PROCLAIM (Device) $19,264
- Proclaim IPG (Device) $6,231
- Proclaim Family of SCS IPGs (Device) $3,835
- Senza Spinal Cord Stimulation System (Device) $2,971
- IonicRF Generator (Device) $2,275
- Intracept (Device) $1,392
- Senza (Device) $1,378
- SPRINT PNS System (Device) $1,349
- Prospera (Device) $1,296
- Omnia (Device) $1,293
- DRG IPGs (Device) $1,249
- VANTA ADAPTIVESTIM (Device) $1,127
- INTELLIS ADAPTIVESTIM (Device) $1,032
- ACCURIAN (Device) $928.87
- Superion ISS (Device) $867.04
- UBRELVY (Drug) $780.39
- ReActiv8 (Device) $775.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.